Ondansetron Injection
Product Images NDC 63323-374

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 63323-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ond08 0004 01)

Chemical structure of Ondansetron Hydrochloride dihydrate showing its molecular composition including the indole group, methyl substitutions, and imidazole ring with hydrochloride and dihydrate components.*

FDA Label Image

Fresenius Kabi Logo (Ond08 0004 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ondansetron Injection, USP)

Label for Ondansetron Injection, USP 4 mg per 2 mL (2 mg per mL) in a 2 mL single dose vial. The label indicates use for intramuscular or intravenous administration and states usual dosage instructions are in the package insert. Manufactured by Fresenius Kabi USA, LLC. Includes NDC 63323-373-00 and barcode.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ondansetron Injection, USP)

Ondansetron Injection, USP 4 mg per 2 mL (2 mg per mL) single dose vials, preservative-free, for intramuscular or intravenous use. Each mL contains 2 mg ondansetron hydrochloride and other components as buffers. Pack of 25 vials labeled by Fresenius Kabi USA, LLC. Storage at 2° to 25°C with protection from light indicated.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ondansetron Injection, USP)

Ondansetron Injection USP 40 mg per 20 mL (2 mg per mL) multiple dose vial label by Fresenius Kabi USA, LLC. For intramuscular or intravenous use. Detailed ingredient and storage information visible, including NDC 63323-374-20, with barcode and lot/expiration section.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ondansetron Injection, USP)

Ondansetron Injection USP 40 mg per 20 mL (2 mg per mL) vial label by Fresenius Kabi USA, LLC. The label includes dosage strength, sterile contents, dosage form as injection, route instructions for intramuscular or intravenous use, storage instructions, and manufacturer details. The vial is a 20 mL multiple dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.